| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/28/1994 | EP0616535A1 Method of treating viral infections |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | EP0563255B1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
| 09/28/1994 | EP0539451B1 Vinylsulphonyl pristinamycin and preparation thereof |
| 09/28/1994 | EP0528847B1 Soluble, truncated gamma-interferon receptors |
| 09/28/1994 | EP0506836B1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
| 09/28/1994 | EP0489732B1 A uv-induced factor for immunosuppression |
| 09/28/1994 | EP0372063B1 Human myeloperoxydasis and its therapeutic application |
| 09/28/1994 | EP0222835B1 Oral vaccines |
| 09/28/1994 | CN1092780A Method for minimizing and containing ischemic and reperfusion injury |
| 09/28/1994 | CN1092767A Spiro piperdines and homologs promote release of growth hormone |
| 09/27/1994 | US5350840 Diagnosis |
| 09/27/1994 | US5350836 Growth hormone antagonists |
| 09/27/1994 | US5350835 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 09/27/1994 | US5350741 Enteric formulations of physiologically active peptides and proteins |
| 09/27/1994 | US5350687 Antibodies which bind to novel lymphokine related peptides |
| 09/27/1994 | US5350683 DNA encoding type II interleukin-1 receptors |
| 09/27/1994 | US5350582 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof |
| 09/27/1994 | US5350578 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 09/27/1994 | US5350574 Immunosuppressive agent for preventing organ rejection |
| 09/27/1994 | CA2119090A1 Compositions for controlled release of biologically active tgf-.beta. |
| 09/27/1994 | CA1332150C Pharmaceutical compositions comprising cyclosporins |
| 09/27/1994 | CA1332149C Therapeutic agent for thrombocytopenia |
| 09/24/1994 | CA2118675A1 Transport protein gene from the huntington's disease region |
| 09/21/1994 | EP0615978A1 Peptide derivatives of the boronic acid having protease inhibiting activity, process for their production and pharmaceutical compositions comprising them |
| 09/21/1994 | EP0615977A1 Spiro piperidines and homologs which promote release of growth hormone |
| 09/21/1994 | EP0615751A1 Use of tachykinin antagonists in the treatment of emesis |
| 09/21/1994 | EP0615747A1 Hemoglobin-encapsulating liposome and method for making the same |
| 09/21/1994 | EP0615548A1 Novel proteases with dna fragmenting activity |
| 09/21/1994 | EP0615546A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 09/21/1994 | EP0615522A1 Muramyl compounds for treatment of septic shock |
| 09/21/1994 | EP0615454A1 Method of preparing a biological adhesive enriched with platelet factors, and application |
| 09/21/1994 | EP0615452A1 Medicament for promoting growth of mammalian nerve |
| 09/21/1994 | EP0615451A1 Novel cytokine that binds cd30 |
| 09/21/1994 | EP0615445A1 Pharmaceutically applicable nanosol and process for preparing the same. |
| 09/21/1994 | EP0615444A1 Peroral administration form for peptidic medicaments, in particular insulin. |
| 09/21/1994 | EP0440688B1 Cpf peptide compositions and uses |
| 09/21/1994 | EP0371017B1 Antibodies against streptococcus |
| 09/21/1994 | CN1092427A Enantiomerically pure SS-D-dioxolane nucleosides with selective anti-hepatitis B virus activity |
| 09/21/1994 | CN1092424A Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 09/21/1994 | CN1092410A Inhibitors of HIV protease useful for the treatment of aids |
| 09/21/1994 | CN1092322A Method of treating hepatitis C in non-responders to interferon treatment |
| 09/21/1994 | CN1092321A Methods for preparing multidrug resistance in cancer cells |
| 09/21/1994 | CN1092294A Melanogenic inhibitor, and method of producing, and using the same |
| 09/20/1994 | US5349056 Modified ciliary neurotrophic factors |
| 09/20/1994 | US5349055 Genetic engineering |
| 09/20/1994 | US5349054 Compositions for blood substitutes |
| 09/20/1994 | US5349053 Chimeric ligand/immunoglobulin molecules and their uses |
| 09/20/1994 | US5349051 Modified interluekin-1β |
| 09/20/1994 | US5349050 Peptides, and antidementia agents containing the same |
| 09/20/1994 | US5348945 Atherosclerosis or nerve damage treatment with heat shock proteins |
| 09/20/1994 | US5348944 Hypotensive agents |
| 09/20/1994 | US5348943 Cosmetic and skin treatment compositions |
| 09/20/1994 | US5348942 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/20/1994 | US5348941 Adenosine phosphates |
| 09/20/1994 | US5348940 Fungicidal antibiotics |
| 09/20/1994 | US5348939 Fibronectin-containing ophthalmic solution, method of preserving an ophthalmic solution, and method of treatment of ophthalmic wounds |
| 09/20/1994 | US5348880 Diagnosis and therapy of human cancer |
| 09/20/1994 | US5348866 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly) peptides |
| 09/20/1994 | US5348864 Mouse vav proto-oncogene DNA and protein sequences |
| 09/20/1994 | US5348863 Process for the enzymatic preparation of basic fibroblast growth factor |
| 09/20/1994 | US5348852 Diagnostic and therapeutic compositions |
| 09/20/1994 | US5348740 Tapeworm |
| 09/20/1994 | US5348739 Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists |
| 09/20/1994 | US5348729 Administering antagonists, measuring hormone level |
| 09/20/1994 | CA1332044C Swine growth promotion |
| 09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
| 09/15/1994 | WO1994020637A1 Fertility regulation with transforming growth factor beta |
| 09/15/1994 | WO1994020632A1 Anti-hiv monoclonal antibody |
| 09/15/1994 | WO1994020625A1 Method for inducing tumor cell death |
| 09/15/1994 | WO1994020623A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | WO1994020619A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/15/1994 | WO1994020616A1 Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas |
| 09/15/1994 | WO1994020615A1 Bone stimulating factor |
| 09/15/1994 | WO1994020614A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 09/15/1994 | WO1994020610A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 09/15/1994 | WO1994020541A1 Collagenase activity inhibitor and cosmetic composition containing same |
| 09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 09/15/1994 | WO1994020537A1 Non-glycosylated tfpi analogues |
| 09/15/1994 | WO1994020536A1 Methods, compositions, and kits for diagnosing lyme disease |
| 09/15/1994 | WO1994020535A1 ECOTIN AS A FACTOR Xa, XIa, AND XIIa INHIBITOR |
| 09/15/1994 | WO1994020534A1 Vasonatrin peptide and analogs thereof |
| 09/15/1994 | WO1994020533A1 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020531A1 Physiologically active peptide |
| 09/15/1994 | WO1994020529A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 09/15/1994 | WO1994020528A1 Inhibitors of herpes viral ribonucleotide reductase |
| 09/15/1994 | WO1994020527A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 09/15/1994 | WO1994020526A1 Peptide boronic acid derivatives having protease inhibiting activity |
| 09/15/1994 | WO1994020524A1 Therapeutic fibrinogen compositions |
| 09/15/1994 | WO1994020522A1 Oligodendroglial trophic factor and methods of use thereof |
| 09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | WO1994020512A2 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 09/15/1994 | WO1994020487A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents |
| 09/15/1994 | WO1994020468A1 4-aminopyridines, their production and use as an antithrombosis agent |
| 09/15/1994 | WO1994020145A1 Use of low density lipoprotein with cytotoxic substances |
| 09/15/1994 | WO1994020142A1 Assays and therapeutic methods based on lymphocyte chemoattractants |
| 09/15/1994 | WO1994020139A1 Use of anti-tnf antibodies as medicament for the therapy of heart insufficiency (weakness of the heart muscle) |
| 09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/15/1994 | WO1994020132A1 A method of treating a mammal with a biologically active compound |